CIS Pharma is a privately held biopharmaceutical company based in the Basel Area, Switzerland. We develop next-gen immuno-conjugates, ADCs and radioligand treatments for cancer patients with poor prognosis and prone to high spread of metastases. Our assets include two targeting moieties against CD 171 and CD 276, and a polymer carrier technology to overcome the current limitations of immuno-conjugates. The technology offers high-yield labeling of proteins, increases DAR and creates precision combination therapies.
View Top Employees from CIS PharmaWebsite | http://www.cis-pharma.com |
Revenue | $6 million |
Employees | 7 (7 on RocketReach) |
Founded | 1952 |
Address | 159 Hauptstrasse, Bubendorf, Basel 4416, CH |
Phone | +41 61 935 53 23 |
Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 9 Million |
Keywords | Ticket Tup, Cis Pharma Multidose, Cis Pharma Multi Dosing + 2019, Ophthalmic Devices Innovation Creative Products |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular CIS Pharma employee's phone or email?
The CIS Pharma annual revenue was $6 million in 2024.
7 people are employed at CIS Pharma.
CIS Pharma is based in Bubendorf, Basel.
The NAICS codes for CIS Pharma are [325, 32541, 3254, 32].
The SIC codes for CIS Pharma are [28, 283].